Osthole inhibits osteoclasts formation and bone resorption by regulating NF-κB signaling and NFATc1 activations stimulated by RANKL.

Yong Ma,Lining Wang,Suyang Zheng,Jiake Xu,Yalan Pan,Pengcheng Tu,Jie Sun,Yang Guo
DOI: https://doi.org/10.1002/jcb.28886
2019-01-01
Journal of Cellular Biochemistry
Abstract:Chinese herbal medicine Fructus Cnidii has an outstanding effect on chronic lumbar pain and impotence, also has been used against osteoporosis with high frequency. Yet, the mechanisms of osthole, a derivative of Fructus Cnidii, on osteoclasts remains barely known. In this study, it was found out that osthole (10(-6)mol/L, 10(-5)mol/L) had the influence of inhibiting osteoclast formation and bone resorptive activities induced by receptor activator of nuclear factor kappa B ligand (RANKL), rather than affecting the viability of osteoclast-like cells. Furthermore, osthole could also inhibit the messenger RNA expressions of c-Src, tartrate-resistant acid phosphatase, beta 3-Integrin, matrix metallopeptidase 9, and cathepsin K. The results of the mechanistic study indicated that osthole regulated the nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) and nuclear factor-kappa B (NF-kappa B) activations following the RANKL stimulation. These findings suggested that the inhibitory effects of osthole were associated with restraining the activations of NFATc1 and NF-kappa B induced by RANKL. Thus osthole can be used as a potential treatment for abnormal bone-resorption related diseases.
What problem does this paper attempt to address?